An open label single arm clinical study to evaluate the effect of kalyanaka guda in sutika pandu

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054034

Enrollment

Registered

2023-06-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I998- Other disorder of circulatory system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects fulfilling diagnostic criteria 2. Age group of 21-34yr 3. Subject irrespective of mode of delivery (like-cesarean, forceps, vacuum delivery) 4. Puerperal women having laboratory findings of Hemoglobin percentage between 7-10.9gm% after 24 hours of post-natal

Exclusion criteria

Exclusion criteria: 1. subjects having Hemoglobin percentage below 7gm% 2. subjects diagnosed with systemic disorders like gestational hypertension, Type 2 Diabetes mellitus, and Renal insufficiency. 3. All types of diagnosed cases of secondary anemia, thalassemia, sickle cell anemia.

Design outcomes

Primary

Measure	Time frame
This study is expected to cure sutika pandu and to increase Hb in sutikaTimepoint: 45days	—

Secondary

Measure	Time frame
nilTimepoint: -	—

Countries

India

Contacts

Public ContactDr Supriya

Rajiv Gandhi University of Health Sciences Bangalore

drroopah@sdmayurbanglalore.in9844271762

Outcome results